JavaScript is disabled in your browser. You can still read and search, but features like search previews, menus, and forms may not work until it's enabled.

From prohibited to prescribed: The rescheduling of MDMA and psilocybin in Australia

Octavian Dixon Ritchie, Cameron N Donley, Gabrielle Dixon Ritchie

Drug Science Policy and Law January 1, 2023 DOI: 10.1177/20503245231198472 via OpenAlex

Relevant Not relevant

Study at a glance

Characteristics	Peer reviewed
Topics	MDMA Psilocybin
Keywords	Hallucinogen Psychology Business
Citations	21

Abstract

No abstract available from the source.

The down-scheduling of MDMA and psilocybin(e): Too fast and too soon Australian & New Zealand Journal of Psychiatry May 10, 2023 22 citations via OpenAlex
Daily briefing: Australia will be first to prescribe these psychedelics as medicines Nature June 30, 2023 1 citation via OpenAlex
The Australia story: Current status and future challenges for the clinical applications of psychedelics British Journal of Pharmacology December 19, 2024 21 citations via OpenAlex
Australia to prescribe MDMA and psilocybin for PTSD and depression in world first Nature July 13, 2023 55 citations via Springer Nature
Is it now time to prepare psychiatry for a psychedelic future? The British Journal of Psychiatry May 20, 2024 18 citations via OpenAlex

Explore topics

MDMA Psilocybin

Comments

No comments yet.

Log in to comment